Bank of New Hampshire’s Bristol-Myers Squibb BMY Stock Holding History

Bank of New Hampshire’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$406K	Sell	7,042 -10	-0.1%	-$574	0.08%	154
2026 Q1	$428K	Buy	7,052 +10	+0.1%	+$583	0.1%	143
2025 Q4	$380K	Hold	7,042	–	–	0.09%	151
2025 Q3	$318K	Hold	7,042	–	–	0.07%	158
2025 Q2	$326K	Sell	7,042 -255	-3%	-$12.5K	0.08%	157
2025 Q1	$445K	Buy	7,297 +165	+2%	+$9.62K	0.12%	137
2024 Q4	$403K	Hold	7,132	–	–	0.1%	144
2024 Q3	$369K	Sell	7,132 -3,840	-35%	-$180K	0.09%	150
2024 Q2	$456K	Sell	10,972 -125	-1%	-$5.59K	0.12%	136
2024 Q1	$602K	Sell	11,097 -1,645	-13%	-$83.8K	0.16%	123
2023 Q4	$654K	Sell	12,742 -11,015	-46%	-$578K	0.19%	114
2023 Q3	$1.38M	Sell	23,757 -4	-0%	-$245	0.41%	70
2023 Q2	$1.52M	Sell	23,761 -120	-0.5%	-$8.05K	0.43%	67
2023 Q1	$1.66M	Buy	23,881 +240	+1%	+$16.9K	0.5%	59
2022 Q4	$1.7M	Buy	23,641 +892	+4%	+$67.3K	0.51%	57
2022 Q3	$1.62M	Buy	22,749 +173	+0.8%	+$12.6K	0.51%	58
2022 Q2	$1.74M	Buy	22,576 +7,398	+49%	+$563K	0.5%	56
2022 Q1	$1.11M	Buy	15,178 +880	+6%	+$59.1K	0.27%	97
2021 Q4	$892K	Buy	14,298 +1,865	+15%	+$109K	0.22%	116
2021 Q3	$831K	Hold	12,433	–	–	0.22%	114
2021 Q2	$831K	Buy	+12,433	New	+$811K	0.22%	114

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Bank of New Hampshire's BMY Position: Q2 2026 in Review

Bank of New Hampshire reduced its Bristol-Myers Squibb (BMY) stake by 0.14% in Q2 2026, selling an estimated $574 and leaving 7,042 shares worth $406K. The position accounts for 0.08% of the portfolio, ranked #154.

Bank of New Hampshire first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.74M in Q2 2022. 1,720 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bank of New Hampshire held 7,042 shares of Bristol-Myers Squibb worth $406K as of Q2 2026.
Bank of New Hampshire sold 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $574.
Bristol-Myers Squibb made up 0.08% of Bank of New Hampshire's portfolio in Q2 2026, its #154 holding.
Bank of New Hampshire first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
Bank of New Hampshire's Bristol-Myers Squibb position peaked at $1.74M in Q2 2022.
1,720 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.